Alpine Woods Capital Investors »

Crispr Therapeutics shares owned by Alpine Woods Capital Investors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Alpine Woods Capital Investors from 13F filings

Historical chart of Alpine Woods Capital Investors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Alpine Woods Capital Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Alpine Woods Capital Investors

Quarter filed Position value Share count Share price at filing
2024-09-30 $314k 5.7k 54.86
2021-12-31 $3.2M 43k 75.78
2021-09-30 $7.6M 68k 111.93
2021-06-30 $11M 68k 161.89
2021-03-31 $4.8M 40k 121.86
2020-12-31 $5.4M 35k 153.12
2020-09-30 $2.4M 28k 83.65
2020-06-30 $1.8M 25k 73.50
2020-03-31 $600k 14k 42.41
2019-12-31 $616k 10k 60.94
2019-09-30 $416k 10k 40.95
2019-06-30 $478k 10k 47.06
2019-03-31 $363k 10k 35.74
2018-12-31 $290k 10k 28.55
2018-09-30 $449k 10k 44.39